Associated Papers
Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.
Hirvensalo P et al.
Clinical Pharmacology and Therapeutics, 2018
28940478 (PubMed )
Supplement: CPT-104-158-s005.pdf
A common polymorphic variant of UGT1A5 displays increased activity due to optimized cofactor binding.
Yang F et al.
Febs Letters, 2018
Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol.
Gonzalez-Covarrubias V et al.
Frontiers in Pharmacology, 2017
29218011 (PubMed )
Supplement: Table1.XLSX › ST1_targetgenes
Genetic variations and haplotype diversity of the UGT1 gene cluster in the Chinese population.
Yang J et al.
Plos One, 2012
Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.
Yea SS et al.
Therapeutic Drug Monitoring, 2008
Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus.
Thomas SS et al.
Human Mutation, 2006
Select a paper to view details